Financials

  • Market Capitalization 1.09 B
  • Employee 121
  • Founded 2013
  • CEO N/A
  • Website www.solidbio.com
  • Headquarter Delaware, United States
  • FIGI BBG00JN4FXG8
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.83
Price to sales ratio
530.1

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2377
JANX
Janux Therapeutics, Inc. - Common Stock
18.78 USD-0.58%+7.93%+25.87%-18.70%1.15 B USD
2388
SVRA
Savara, Inc. - Common Stock
5.49 USD-2.14%-0.90%+4.17%+67.89%1.13 B USD
2421
AVTX
Avalo Therapeutics, Inc. - Common Stock
20.05 USD-2.43%+0.15%+1.88%+112.85%1.08 B USD
2428
CADL
Candel Therapeutics, Inc. - Common Stock
13.75 USD+3.54%+8.70%+40.16%+135.04%1.05 B USD

Frequently asked questions about Solid Biosciences Inc. Common Stock

What is the Solid Biosciences Inc. Common Stock stock price today?

The current price of Solid Biosciences Inc. Common Stock (SLDB) is 10.13. Over the past 24 hours, the stock has changed by +4.22%. Follow the SLDB chart for real-time price dynamics.

What is the stock ticker of Solid Biosciences Inc. Common Stock?

Solid Biosciences Inc. Common Stock trades under the ticker SLDB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Solid Biosciences Inc. Common Stock stock going up?

SLDB has changed by +8.46% over the last week, +27.26% over the last month, and +77.72% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Solid Biosciences Inc. Common Stock?

Solid Biosciences Inc. Common Stock currently has a market capitalization of 1.09 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Solid Biosciences Inc. Common Stock earnings last quarter?

Last quarter, Solid Biosciences Inc. Common Stock reported earnings of -0.38 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Solid Biosciences Inc. Common Stock revenue for the last quarter?

Solid Biosciences Inc. Common Stock reported quarterly revenue of -850 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Solid Biosciences Inc. Common Stock net income for the last quarter?

Solid Biosciences Inc. Common Stock reported net income of -54.8 M for the last quarter. The previous quarter showed -56.74 M, which means net income changed by +3.42%.

How many employees does Solid Biosciences Inc. Common Stock have?

As of the latest available data, Solid Biosciences Inc. Common Stock has 121 employees. Workforce size can provide additional context about the company's scale and operations.

What is Solid Biosciences Inc. Common Stock EBITDA?

Solid Biosciences Inc. Common Stock EBITDA is -59.6 M, and its EBITDA margin is 7 011.65%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Solid Biosciences Inc. Common Stock stock?

You can buy Solid Biosciences Inc. Common Stock (SLDB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Solid Biosciences Inc. Common Stock stock?

Investing in Solid Biosciences Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLDB chart and related analysis on metatrader.com as part of your research.

News